£201k
−16%vs Dec 2023Active12541462Private limited companyOxford
ACT THERAPEUTICS LTD
Significant control: Exact Therapeutics As (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Act Therapeutics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Act Therapeutics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
ACT THERAPEUTICS LTD is an active private limited company (company number 12541462) incorporated on 31 March 2020, registered in Oxford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2024, showing net assets of £201k and cash of £7,659, with 1 employee on average. Net assets fell 16% on the prior period (£239k).
Peer position · net assets
By net assets it sits in the upper half of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
02
Ownership and control
- Exact Therapeutics As
- owns 75–100% of shares
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 31 March 20206 yrs ago
- Next accounts due
- 30 September 202627 days overdue
- Confirmation statement due
- 14 April 2027in 169 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£7,659
+25%vs Dec 2023Not reported
1
vs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | £201k | £7,659 | £96k | £5,728 | — | — | 1 |
| 31 December 2023 | £239k | £6,149 | £113k | £16k | — | — | 0 |
Current ratio18.1Current assets ÷ creditors within one year
Cash per employee£7,659Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £200,889 at 31 December 2024
- Current assets at least 1.5× creditors within one yearCurrent ratio 18.1
- Incorporated five or more years agoIncorporated 31 March 2020
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 169 days
- Next accounts due27 days overdue
- Accounts period endNet assets £201k · small accounts
- Accounts period endNet assets £239k · small accounts
- Incorporated
08
Similar companies in Oxford
- EREBAGEN LTDKidlington · inc. Mar 2020
- LATUS THERAPEUTICS LIMITEDOxford · inc. Apr 2020
- METAGUIDEX LTDHeadington · inc. Apr 2020
- MEDIMAB BIOTHERAPEUTICS LTDAbingdon · inc. Mar 2020
- NEBUQUINE LIMITEDWitney · inc. Apr 2020
- OXFORD CANCER ANALYTICS LTDOxford · inc. Feb 2020
All companies incorporated on 31 March 2020 · in Mar 2020.
09
Reminders for ACT THERAPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.